Category: Zoll Medical Corp.
A federal judge shoots down bids by Philips and Zoll to dismiss a patent infringement case over automated external defibrillator technology.
The Dept. of Defense awards Zoll a highly competitive medical device supply contract worth up to $210 million over 5 years for defibrillators, warmers, monitors and infusers.
Zoll CEO Richard Packer goes out of his way to avoid layoffs, even if it means cutting profits to the bone.
Photograph by Carolyn Bick
Richard Packer has been with Zoll Medical since 1992, taking on various roles in operations and finance before landing the corner office.
Zoll makes it 2nd buy this month with the acquisition of life-support systems assets of German-based LIFEBRIDGE Medizintechnik for an undisclosed amount.
Massachusetts-based Asahi Kasei (TYO:3407) subsidiary Zoll Medical touted its 2nd acquisition this month, this time nabbing assets of German-based Lifebridge Medizintechnik.
Asahi Kasei subsidiary Zoll Medical announces the closed-doors acquisition of CoAxia Inc.'s catheter-based intellectual property, including the NeuroFlo and FloControl blood flow redistribution devices.
InspireMD nets nearly $23 million from a public stock offering, saying it plans to use the proceeds to pursue U.S. approval of its MGuard coronary and carotid stents.
InspireMD (OTC:NSPR) said it added some $23 million to its coffers in a public stock offering.
The Tel Aviv-based medical device company makes the MGuard device, designed to protect against embolism after stenting procedures.
Zoll Medical wins a lawsuit and an injunction preventing Germany's ELan Med GmbH from manufacturing or selling products designed to work with Zoll's Intravascular Temperature Management Systems.
Massachusetts medical device maker Zoll Medical touted a legal win against Germany's ELan Med GmbH, landing an injunction that prevents ELan from manufacturing or selling any infringing products.
A judge for the District Court of Munich, Germany, ruled in Zoll's favor that certain of ELan's devices infringe on Zoll's for its Intravascular Temperature Management Systems patents, according to a press release.